AstraZeneca PLC discovers, develops, manufactures, and markets prescription pharmaceuticals in the areas of cardiovascular, gastrointestinal, neuroscience, oncology, respiratory and inflammation, and infection worldwide. Its products include Arimidex for hormonal breast cancer; Crestor that provides treatment for managing cholesterol levels; Nexium for acid-related diseases; Seroquel, an atypical anti-psychotic therapy for treating schizophrenia and bipolar mania; and Symbicort for the maintenan ...

The history of AstraZeneca goes back nearly 100 years. In that time we’ve produced medications for cancer, heart disease, mental illness, stomach, infections and respiratory conditions, and our commitment to research grows stronger every year.

Today, not only are we working to discover the next new medicine, but we’re also working to help make healthcare a more meaningful, more personal experience for patients. The key to this goal is empowerment. By empowering patients with information, and ...

Guidant has merged with Boston Scientific, a worldwide developer, manufacturer, and marketer of medical devices that advance the practice of less-invasive medicine across a wide range of specialties. As a part of that merger, Guidant's vascular and endovascular businesses have been acquired by Abbott Vascular.

Baxter International Inc. (NYSE:BAX) is a global healthcare company that, through its subsidiaries assists healthcare professionals and their patients with treatment of complex medical conditions including hemophilia, immune disorders, kidney disease, cancer, trauma and other conditions. With 2006 sales of $10.4 billion, and approximately 45,000 employees, Baxter applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.